Skip to main content
    V

    Veru Inc (VERU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.08
    -0.01 (-0.48%)

    Market Cap: $35.64M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Veru Inc (VERU) Financials: Revenue, Profit and Cash Flow

    Updated Aug 10, 2026. Financial statements from company filings, amounts in US dollars.

    VERU reported revenue of $0 for the fiscal year ended Sep 30, 2025. That year, net income was -$22.73M, operating cash flow was -$30.04M and free cash flow was -$30.04M. The quarter ended Jun 30, 2026 had revenue of $0 and net income of -$6.99M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Sep 2025, with an operating loss of $24.75M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$0N/AN/AN/AN/A
    Sep 2024$0-100.0%N/AN/AN/A
    Sep 2023$16.30M-58.6%46.4%-575.5%-571.6%
    Sep 2022$39.35M-35.8%77.7%-212.1%-213.5%
    Sep 2021$61.26M+43.8%78.2%21.2%12.1%
    Sep 2020$42.59M+33.9%72.3%-34.6%-44.5%
    Sep 2019$31.80M+100.5%68.1%-20.2%-37.8%
    Sep 2018$15.86M+16.2%55.3%-131.6%-150.9%
    Sep 2017$13.66M-38.3%51.4%-62.2%-48.4%
    Sep 2016$22.13MN/A60.3%13.6%1.6%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue$0$0$16.30M$39.35M$61.26M$42.59M$31.80M$15.86M$13.66M$22.13M
    Cost of revenue$0$0$8.73M$8.75M$13.33M$11.81M$10.15M$7.09M$6.64M$8.78M
    Gross profit$0$0$7.57M$30.59M$47.93M$30.79M$21.66M$8.77M$7.02M$13.35M
    Research and development$15.59M$12.78M$51.20M$70.91M$32.69M$16.94M$13.74M$10.85M$3.08M$99.39K
    Operating income-$24.75M-$36.17M-$93.78M-$83.49M$12.97M-$14.75M-$6.44M-$20.87M-$8.49M$3.02M
    Net income-$22.73M-$37.80M-$93.15M-$84.04M$7.39M-$18.97M-$12.02M-$23.94M-$6.61M$344.73K
    EBITDA-$23.57M-$34.22M-$89.98M-$79.23MN/AN/AN/A-$19.67M-$8.12M$3.24M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$0$0$0$247.06K$0$0$0$6.66M$0$0$0$3.86M
    Gross profit$0$0$0-$28.57K$0$0$0$2.69M$0$0$0$1.54M
    Operating income-$7.71M-$7.22M-$5.42M$1.17M-$7.55M-$8.12M-$10.25M-$9.34M-$10.55M-$8.89M-$7.39M-$8.18M
    Net income-$6.99M-$2.74M-$5.33M$1.45M-$7.33M-$7.90M-$8.95M-$8.53M-$10.97M-$10.03M-$8.28M-$8.13M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, cash and equivalents exceeded short-term debt of $758.95K by $15.04M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets$29.84M$60.42M$50.02M$135.36M$178.15M$51.54M$53.63M$48.45M$55.34M$38.62M
    Current assets$18.92M$35.22M$22.93M$104.00M$151.75M$27.01M$16.81M$11.18M$10.30M$16.29M
    Cash and equivalents$15.79M$24.92M$9.63M$80.19M$122.36M$13.59M$6.30M$3.76M$3.28M$2.39M
    Total liabilities$11.50M$28.10M$30.34M$52.56M$25.85M$21.43M$21.30M$18.97M$6.88M$4.69M
    Short-term debt$758.95K$2.09M$1.90M$2.13M$3.74M$5.84M$5.39M$6.69MN/AN/A
    Long-term debtN/A$8.85M$8.87M$9.66M$9.40M$5.62M$2.89M$2.70M$0$0
    Shareholder equity$18.33M$32.32M$19.68M$82.80M$152.29M$30.11M$32.33M$29.48M$48.45M$33.93M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$37.03M$43.08M$47.57M$29.84M$27.33M$32.67M$39.83M$60.42M$64.63M$71.80M$80.57M$50.02M
    Total liabilities$8.65M$8.30M$10.44M$11.50M$11.99M$11.62M$13.20M$28.10M$27.01M$26.59M$28.96M$30.34M
    Cash and equivalents$23.88M$27.60M$32.99M$15.79M$15.01M$20.02M$26.61M$24.92M$29.15M$34.74M$40.58M$9.63M
    Shareholder equity$28.38M$34.79M$37.12M$18.33M$15.34M$21.05M$26.63M$32.32M$37.62M$45.21M$51.60M$19.68M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Sep 2025.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow-$30.04M-$21.68M-$88.01M-$47.51M-$15.57M-$1.93M-$5.49M-$11.55M$982.89K-$1.71M
    Capital expenditures$1.08K$158.32K$665.70K$733.05K$376.65K$105.76K$108.52K$50.65K$133.49K$6.37K
    Free cash flow-$30.04M-$21.84M-$88.68M-$48.24M-$15.95M-$2.04M-$5.59M-$11.60M$849.40K-$1.72M
    Dividends paidN/AN/AN/AN/AN/A$13.82MN/A$10.07M$0$0
    Share repurchasesN/AN/A$263.76K$0$137.69K$0$0$77.84KN/AN/A
    Investing cash flow$25.14M$146.21K$6.33M$4.27M$14.62M-$105.76K-$108.52K-$50.65K-$90.37K-$6.37K
    Financing cash flow-$4.22M$36.83M$11.11M$1.07M$109.72M$9.33M$8.13M$12.08M$0$0
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$5.47M-$8.91M-$6.17M-$5.49M-$5.48M-$7.74M-$11.33M-$4.37M-$5.65M-$5.65M-$6.02M-$9.49M
    Capital expendituresN/A$5$0$4$2$3$1.08K$63.04K$54.63K$40.66K$0$212.87K
    Free cash flowN/A-$8.91M-$6.17M-$5.49M-$5.48M-$7.74M-$11.33M-$4.43M-$5.70M-$5.69M-$6.02M-$9.71M
    Last 12 quarters

    Frequently Asked Questions About VERU

    What is VERU's annual revenue?

    VERU reported revenue of $0 for the fiscal year ended Sep 30, 2025.

    Is VERU profitable?

    No. VERU reported net income of -$22.73M for the fiscal year ended Sep 30, 2025.

    How much free cash flow does VERU generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of -$30.04M minus capital expenditures of $1.08K produced free cash flow of -$30.04M.

    How much debt does VERU have?

    The balance sheet dated Sep 30, 2025 reported short-term debt of $758.95K and cash and equivalents of $15.79M.